TRELSTAR 22.5 MG
TRIPTORELIN (TRIPTORELIN PAMOATE) : 22.5 MG · DIN 02412322 · KNIGHT THERAPEUTICS INC.
Health Canada status: MARKETED
What is TRELSTAR?
TRELSTAR 22.5 MG contains TRIPTORELIN (TRIPTORELIN PAMOATE) : 22.5 MG. It is listed in the Health Canada Drug Product Database under DIN 02412322, held by KNIGHT THERAPEUTICS INC., supplied as POWDER FOR SUSPENSION, SUSTAINED-RELEASE for INTRAMUSCULAR administration. Health Canada currently lists it as marketed, status dated 14-Oct-2020. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is TRELSTAR used for?
Management and relief of chronic pain associated with endometriosis; palliative treatment of hormone dependent advanced carcinoma of the prostate gland (stage D2).
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02412322 |
|---|---|
| Brand name | TRELSTAR |
| Generic / active ingredient | TRIPTORELIN (TRIPTORELIN PAMOATE) : 22.5 MG |
| Manufacturer | KNIGHT THERAPEUTICS INC. |
| Strength | 22.5 MG |
| Dosage form | POWDER FOR SUSPENSION, SUSTAINED-RELEASE |
| Route of administration | INTRAMUSCULAR |
| Schedule | Prescription |
| ATC code | L02AE04 TRIPTORELIN |
| AHFS class | 10:00.00 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 14-Oct-2020 |
| Original market date | 2013-10-16 00:00:00 |
How is it administered?
Intramuscular injection. Endometriosis: 3.75 mg every 28 days (max 6 months). Prostate Cancer: 3.75 mg monthly, 11.25 mg every 3 months, or 22.5 mg every 6 months.
Included because it drives pack selection and wastage. Consult the monograph.
How is it stored and handled?
Store at 15-30°C. Do not freeze. (Note: General template implies room temperature; specific text mentions 15-30°C in standard practice for these formulations).
How is it supplied?
Single-dose vials; available with MIXJECT delivery system, vial adapter system, or as vial only. Includes 21-gauge needle and 2 mL sterile water for injection.
Contraindications
Hypersensitivity to LHRH or LHRH agonists; pregnancy or potential pregnancy; nursing women; women with undiagnosed abnormal vaginal bleeding.
Warnings and precautions
Clinical testosterone flare; osteoporosis/bone loss; pituitary apoplexy; convulsions; depression; idiopathic intracranial hypertension; spinal cord compression (prostate cancer).
What can be used instead?
Other Canadian products sharing ATC code L02AE04 TRIPTORELIN. 4 of 4 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| DECAPEPTYL | 0.1 MG | SOLUTION | FERRING INC | MARKETED | DIN 02389282 |
| TRELSTAR | 11.25 MG | POWDER FOR SUSPENSION, SUSTAINED-RELEASE | KNIGHT THERAPEUTICS INC. | MARKETED | DIN 02243856 |
| TRELSTAR | 3.75 MG | POWDER FOR SUSPENSION, SUSTAINED-RELEASE | KNIGHT THERAPEUTICS INC. | MARKETED | DIN 02240000 |
Who else supplies TRIPTORELIN worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. TRIPTORELIN appears in 47 registered pack listings across 11 markets, published on 9 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.